ELEVATE High-Risk PCI Pivotal Study
NCT: NCT07001332 · RECRUITING
NCT IDNCT07001332
StatusRECRUITING
Start Date2025-07-25
Completion2027-09-16
Brief Summary
The ELEVATE III Pivotal Study is a prospective, multi-center, open-label, interventional, randomized, controlled study with an active control group. The study is intended to assess the safety and efficacy of the Elevate™ percutaneous Left Ventricular Assist Device System in patients referred to high-risk percutaneous coronary interventions (HR-PCI).
Frequently Asked Questions
What is ELEVATE High-Risk PCI Pivotal Study?
ELEVATE High-Risk PCI Pivotal Study is a clinical trial registered under NCT07001332. Current status: RECRUITING.
What is the status of NCT07001332?
The current status of NCT07001332 (ELEVATE High-Risk PCI Pivotal Study) is: RECRUITING.
When did ELEVATE High-Risk PCI Pivotal Study start?
ELEVATE High-Risk PCI Pivotal Study started on 2025-07-25.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.